Scleral Fixation of Intraocular Lenses: Outcomes From MA60AC Intraocular Lens Fixation With a 10-0 Prolene Suture vs Akreos Intraocular Lens Fixation With a Polytetrafluoroethylene (Gore-Tex) Suture

巩膜固定人工晶状体:MA60AC人工晶状体采用10-0聚丙烯缝线固定与Akreos人工晶状体采用聚四氟乙烯(戈尔特斯)缝线固定的疗效比较

阅读:1

Abstract

Purpose: To compare the outcomes of intraocular lens (IOL) scleral fixation using Akreos (Bausch + Lomb) lenses with polytetrafluoroethylene (Gore-Tex CV-8, W.L. Gore & Associates) sutures vs 3-piece IOLs (Alcon MA60AC) with 10-0 Prolene (Ethicon, a Johnson & Johnson Company) sutures. Methods: Patients undergoing pars plana vitrectomy between January 2019 and July 2021 were retrospectively selected regardless of the technique used. Patients who completed at least 6 months of follow-up were invited to a new clinic visit to evaluate outcomes of their procedures. The protocol included intraocular pressure assessment using a Goldmann tonometer, subjective refraction, corneal topography with a Pentacam HR (Oculus, Optikgeräte GmbH), IOL decentration assessment on biomicroscopy via slitlamp, and optic disc cupping evaluation by indirect ophthalmoscopy. Complications such as corneal edema, ocular hypertension, hypotony, hyphema, IOL decentration, cystoid macular edema, vitreous hemorrhage, suture breakage, retinal detachment, or uveitis-glaucoma-hyphema syndrome were investigated. Results: A total of 20 eyes from 20 participants were classified into 2 groups according to surgical technique: Akreos plus GoreTex (n=11) or MA60AC plus Prolene (n=9). The results showed no statistically significant differences between the 2 groups in terms of refractive outcomes, postoperative complications, or demographic variables, suggesting both techniques provide similar efficacy and safety. Conclusions: Both the Akreos with Gore-Tex and MA60AC with Prolene scleral fixation techniques are effective and safe for patients requiring IOL implantation in the absence of adequate capsular support. Further research is needed to solidify these observations and guide future clinical decisions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。